Insider buying last 90 days
No open-market insider purchases were filed for ALL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Allstate's week centers on third-quarter 2026 results, filed alongside a Form 10-Q for the period ending September 30. The company topped both EPS and revenue estimates, though this compares against earnings of $11.17 per share a year ago. Ahead of the release, one preview had flagged that Property-Liability underwriting income could plunge 55.7% with earnings projected to fall 37.1%, while another piece this week described a weak near-term sentiment pattern alongside a targeted 7.9% gain setup. The company also reported strong prior-quarter results on 5 August 2026, with total revenues of $18.6 billion and net income of $3.2 billion.
Shares closed at $269.06, up 2.9%, sitting above both the 50-day average of $245.85 and the 200-day average of $229.40, with the 50-day above the 200-day. The one-month return stands at 20% and the one-year return at 40.7%, even as the three-month return shows -2.2%. The GekkoIndex reads 48.3, placing the stock in the Neutral zone, down 5.7 over five days. Price sits 5.5% above Gekko Fair Value of $255.08.
No confirmed earnings date appears on the calendar following the last report on 5 August 2026, which beat estimates with $8.99 versus $5.76 expected and produced a 4.8% reaction. Options activity over the past 30 days shows 1 unusual signal, with put premium of $2,036,480 against call premium of $16,585. Analyst consensus across 19 firms includes 9 buy, 7 hold, and 3 sell ratings, with a consensus target of $269.27. Seasonality over 5 years shows the next 20 trading days averaging +3.1%, rising in 3 of those years.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Allstate scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
Above 50 and 200-day
Close $269.06 is above the 50-day ($245.85) and 200-day ($229.40) averages, and the 50-day is above the 200-day.
See the chart48.3, Neutral
Reading 48.3 is in the Neutral zone.
See the GekkoIndex5.5% above
Price is 5.5% above Gekko Fair Value (more than 5% above).
See fair valueLeans bearish
Last 30 days: 1 unusual options signal.
See smart moneyNo data
No confirmed report date on the calendar.
See earnings+3.1% on average
From this point in the calendar, the next 20 trading days averaged +3.1% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Allstate closed at $269.06 on Nov 4, 2026, +40.7% over the past year, inside a 52-week range of $191.13 to $277.22.
Use the left and right arrow keys to read daily values.
Put ALL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Allstate offers property and casualty coverage along with other insurance lines to customers across the United States and Canada. It is widely recognized for personal auto and homeowners policies, alongside coverage for vehicles such as motorcycles, trailers, motor homes, and off-road equipment, plus renters, condo, landlord, boat, umbrella, manufactured home, and scheduled personal property protection. Commercial insurance is also part of its offering, sold under both the Allstate and Encompass names.
The company organizes its work into four segments. Allstate Protection handles the personal and commercial insurance lines described above. Protection Services covers consumer products like device and appliance protection plans, vehicle service contracts, GAP waivers, tire and wheel coverage, roadside assistance, telematics-based data services, and identity protection, under brands such as Allstate Protection Plans, Arity, and Allstate Identity Protection. Allstate Health and Benefits provides life, accident, critical illness, and disability coverage, while Run-off Property-Liability manages older obligations no longer actively sold. Policies reach customers through call centers, agents, brokers, wholesale partners, affinity groups, and online and mobile channels.
Allstate was founded in 1931 and is based in Northbrook, Illinois. Its shares are listed on the NYSE under the ticker ALL.
Allstate’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48.3, in the Neutral zone, down 5.7 points over five sessions.
Down 5.7 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 18 | +1.1% | +10.0% | ||
| Accumulation | 184 | +1.2% | +4.1% | ||
| Neutral (current zone) | 459 | +0.1% | 0.0% | ||
| Distribution | 31 | −0.5% | +2.3% | ||
| Selling | 5 | Too few readings yet | |||
Average ALL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Allstate trades 5.5% above Gekko Fair Value of $255.08, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Allstate shares are worth, recalculated every trading day.
$255.08
Gekko Fair Value, Nov 4, 2026
5.5% Overvalued
At the end of Aug 2026 the price was 3.5% below the estimate.
No open-market insider purchases were filed for Allstate, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ALL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ALL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Allstate has been buying back its own shares.
From company filings.
1signal, 1% of the flagged premium in calls.
Latest: Bearish flow on Nov 3, $2.05M in unusual premium.
1of the funds Gekko tracks holds ALL.
Allstate beat the EPS estimate in 8 of its last 8 reports, moving 2.4% on average across the report.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $8.99 est $5.76 | $15.43B est $15.46B | +4.8% |
| Apr 29, 2026 | $10.65 est $7.24 | $14.63B est $15.07B | +0.4% |
| Feb 4, 2026 | $14.31 est $9.60 | $14.57B est $14.53B | +6.7% |
| Nov 5, 2025 | $11.17 est $7.67 | $17.06B est $15.68B | +1.4% |
| Jul 30, 2025 | $5.94 est $3.25 | $16.62B est $15.21B | +4.8% |
| Apr 30, 2025 | $3.53 est $2.52 | $16.46B est $14.05B | −0.8% |
| Feb 5, 2025 | $7.67 est $5.40 | $16.51B est $13.72B | +0.5% |
| Oct 30, 2024 | $3.91 est $2.36 | $16.63B est $14.57B | 0.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Allstate is $269.27, +0.1% from the last close, from 19 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 19 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 27 | Bank of America Securities | — | — |
| Oct 20 | UBS | $275 | +2.2% |
| Oct 16 | KBW | $232 | −13.8% |
| Oct 16 | Wells Fargo | $236 | −12.3% |
| Oct 16 | Morgan Stanley | $240 | −10.8% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Allstate averaged +3.1% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.7% | 3 of 5 |
| Next 10 trading days | +3.7% | 4 of 5 |
| Next 15 trading days | +5.0% | 4 of 5 |
| Next 20 trading days | +3.1% | 3 of 5 |
| Next 30 trading days | +3.5% | 4 of 5 |
For scale, ALL’s typical 20-trading-day move in either direction is about 4.6%.
Allstate’s market cap is $68.03B, with a P/E ratio of 5.3 and revenue of $70.14B over the last twelve months.
Coverage of Allstate this week reads positive: 2 positive, 1 neutral and 0 negative headlines.
Allstate’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGRProgressive | Neutral | 5.3% above |
| MFCManulife Financial | Neutral | 14.5% above |
| METMetLife | Neutral | 1.1% above |
| AFLAFLAC | Neutral | 7.0% above |
| SLFSun Life Financial | Neutral | 11.2% above |
| AIGAIG | Neutral | 0.3% above |
A peer links to its own page where one exists.
Allstate’s market cap is $68.03B at the Nov 4, 2026 close of $269.06, with 252.9M shares outstanding. The shares trade on a P/E ratio of 5.3.
The consensus analyst 12-month price target for Allstate is $269.27, +0.1% from the last close. Of the 19 firms that rated the stock in the last 90 days, 9 rate it a buy, 7 a hold and 3 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Allstate is overvalued: the Nov 4, 2026 close of $269.06 is 5.5% above Gekko Fair Value of $255.08. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Allstate’s 52-week high is $277.22 and its 52-week low is $191.13; it closed at $269.06 on Nov 4, 2026, +40.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and smart money). The checklist is a description of current data, not a recommendation.
Gekko flagged 1 unusual options signal in Allstate over the last 30 days, with $17K of flagged premium in calls and $2.04M in puts. The latest, bearish flow, was on Nov 3, 2026 with $2.05M in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.